Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Timothy P.M. Whelan"'
Autor:
Walker M. Blanding, MD, Morgan A. Hill, MD, Z.A. Hashmi, MD, Kevin X. Huang, MD, Timothy P.M. Whelan, MD, Luca Paoletti, MD, Kathryn E. Engelhardt, MD, MS, Barry C. Gibney, DO
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100089- (2024)
Background: There remains significant variability in the use of intraoperative mechanical circulatory support in lung transplantation. This report details our outcomes using elective cardiopulmonary bypass (CPB) in lung transplantation. Methods: We p
Externí odkaz:
https://doaj.org/article/a1b337387a164209986bbe185e8b675a
Autor:
Kathleen Oare Lindell, Mohan Madisetti, Tracy Fasolino, MaryChris Pittman, Patrick Coyne, Timothy P.M. Whelan, Martina Mueller, Dee W. Ford
Publikováno v:
Palliative Medicine Reports, Vol 4, Iss 1, Pp 292-299 (2023)
Background: Idiopathic pulmonary fibrosis (IPF) is a serious illness with an unpredictable disease course and survival rates comparable with some cancers. Patients with IPF suffer considerable symptom burden, declining quality of life, and high healt
Externí odkaz:
https://doaj.org/article/4c38075848834112b1fce6de45f79ba0
Autor:
Rebecca A. Gersten, Bhavna Seth, Luis Arellano, Jessica Shore, Lanier O'Hare, Nina Patel, Zeenat Safdar, Rachana Krishna, Yolanda Mageto, Darlene Cochran, Kathleen Lindell, Sonye K. Danoff, Divya Patel, Timothy P.M. Whelan, Traci Adams, Janell Reichuber, Tonya Russell, Heather Bachert, Tracy R. Luckhardt, Lake Morrison, Jane E. Dematte, Ria Edwina Gripaldo, Michael Henderson, Krishna Thavarajah, Rade Tomic
Publikováno v:
Chest. 162(2)
Interstitial lung disease (ILD) results in profound symptom burden and carries high mortality. Palliative care (PC) is dedicated to improving quality of life in patients with serious illness. Early PC provision improves rates of advance care planning
Autor:
Kevin R. Flaherty, Timothy P.M. Whelan, Jesse Roman, Nishant Gupta, David J. Lederer, Yolanda Mageto, Maryl Kreider, Paul Sachs, Hyun J Kim, Joseph A. Lasky, Imre Noth, Ramona Schmid, Sally Suliman, Zeenat Safdar, Mridu Gulati, Christian Hesslinger, Prema Menon, L. Kristin Newby, Robert Overton, Andrew Namen, Leann Silhan, Lake Morrison, Thomas Leonard, John A. Belperio, Marilyn K. Glassberg, Albert Baker, Daniel A. Culver, Scott M. Palmer, Francis Cordova, Rishi Raj, Scott Beegle, Benjamin Strobel, Justin M. Oldham, Mary E. Strek, Tristan J. Huie, Daniel F. Dilling, Jamie L. Todd, Robert J. Kaner, Richard Vinisko, David Hotchkin, Lisa Lancaster, Timothy Liesching, Barry Sigal, Jason Lobo, Kalpalatha Guntupalli, Yi Liu, Megan L. Neely, Joao A. de Andrade, Amy Hajari Case, Doug Lee, Randolph J. Lipchik, Katey Durham, Rajat Walia, Murali Ramaswamy, Tonya D. Russell, Howard J. Huang, Jeremy Tabak, Wael Asi, Rany Condos, Janine Roy
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-13 (2019)
Respiratory Research
Respiratory Research
Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease for which diagnosis and management remain challenging. Defining the circulating proteome in IPF may identify targets for biomarker development. We sought to quantify the cir
Autor:
Anna J. Podolanczuk, Joao A. Andrade, Nishant Gupta, Ather Siddiqi, Megan L. Neely, David J. Lederer, Nina Patel, Jesse Roman, Murali Ramaswamy, Rajat Walia, Yolanda Mageto, Shirin Shafazand, Amy Hajari Case, Joseph A. Lasky, Doug Lee, Kalpalatha K. Guntupalli, Mark P. Steele, Wael Asi, Hyun J Kim, Tracy Luckhardt, Timothy Liesching, Paul Sachs, Mary E. Strek, Sally Suliman, Kevin F. Gibson, Laurie D. Snyder, David Hotchkin, Randolph J. Lipchik, Kevin R. Flaherty, Eric S. White, Justin M. Oldham, Timothy P.M. Whelan, Mary K. Porteous, Imre Noth, Craig S Conoscenti, Prema Menon, Daniel F. Dilling, Jeremy Tabak, John Fitzgerald, Scott Beegle, Marilyn K. Glassberg, Lisa Lancaster, Francis Cordova, Rishi Raj, Tessy Paul, Paul Mohabir, Mridu Gulati, Ayodeji Adegunsoye, Andrew Namen, Tristan J. Huie, Robert J. Kaner, Lake Morrison, Leann Silhan, Rany Condos, David Zhang, Zeenat Safdar, John A. Belperio, Maryl Kreider, Albert Baker, Daniel A. Culver, Tonya D. Russell, Howard J. Huang, Shaun Bender, Barry Sigal, Jason Lobo
Publikováno v:
Respiratory Research
Respiratory Research, Vol 22, Iss 1, Pp 1-9 (2021)
Respiratory Research, Vol 22, Iss 1, Pp 1-9 (2021)
Background Hospitalizations are common among patients with idiopathic pulmonary fibrosis (IPF). We investigated the impact of hospitalizations on outcomes in patients with IPF. Methods The IPF-PRO Registry is an observational US registry that enrolle
Autor:
Paul Sachs, Sally Suliman, Emily C. O'Brien, Kevin R. Flaherty, Tonya D. Russell, Timothy Liesching, Maryl Kreider, Joao Alberto de Andrade, Hyun J Kim, Andrew Namen, Justin M. Oldham, Daniel F. Dilling, Marilyn K. Glassberg, Shaun Bender, Zeenat Safdar, Francis Cordova, Rishi Raj, Wendy Morris, Scott M. Palmer, Barry Sigal, Randolph J. Lipchik, Albert Baker, Daniel A. Culver, Jason Lobo, Doug Lee, Rany Condos, Timothy P.M. Whelan, Anne S. Hellkamp, Thomas Leonard, Kalpalatha K. Guntupalli, Megan L. Neely, Rajat Walia, Joseph A. Lasky, Yolanda Mageto, Wael Asi, John A. Belperio, Scott Beegle, Laurie D. Snyder, Joao A. de Andrade, Amy Hajari Case, Nishant Gupta, Mridu Gulati, Craig S Conoscenti, David J. Lederer, Tristan J. Huie, Julie Fleming, Mary E. Strek, Prema Menon, Robert J. Kaner, Lisa Lancaster, Lake Morrison, Leann Silhan, Jeremy Tabak, Murali Ramaswamy, David Hotchkin
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-10 (2019)
Respiratory Research
Respiratory Research
Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a variable clinical course and high mortality. We used data from a large national US registry of patients with IPF to investigate relationships between patient characteristi
Autor:
Lisa Lancaster, Colin Holtze, Laurie D. Snyder, Chris Mosher, Timothy P.M. Whelan, Craig S Conoscenti, Kevin R. Flaherty, Anne S. Hellkamp, Shaun Bender, Megan L. Neely, Joao A. de Andrade, Imre Noth
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BMJ Open Respiratory Research
BMJ Open Respiratory Research
BackgroundIdiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality. Patient characteristics associated with diagnostic delays are not well described.MethodsSubjects who had not been diagnosed with IPF prior to referral and rec
Autor:
Thomas Leonard, Marilyn K. Glassberg, Mary E. Strek, Yi Liu, Timothy P.M. Whelan, Jeremy Tabak, Hyun J Kim, Francis Cordova, Rishi Raj, Andrew Namen, Lisa Lancaster, Timothy Liesching, Joseph A. Lasky, Sally Suliman, Robert Overton, Murali Ramaswamy, Kevin R. Flaherty, Megan L. Neely, Maryl Kreider, Scott Beegle, Jamie L. Todd, Tristan J. Huie, Scott M. Palmer, Richard Vinisko, Barry Sigal, John A. Belperio, Nishant Gupta, Kalpalatha K. Guntupalli, Tonya D. Russell, Christian Hesslinger, Jason Lobo, Mridu Gulati, Wael Asi, Robert J. Kaner, Rajat Walia, David J. Lederer, David Hotchkin, L. Kristin Newby, Randolph J. Lipchik, Lake Morrison, Paul Sachs, Doug Lee, Justin M. Oldham, Tracey Luckhardt, Leann Silhan, Daniel F. Dilling, Albert Baker, Daniel A. Culver, Yolanda Mageto, Rany Condos, Zeenat Safdar, Mitchell A. Olman, Imre Noth, Prema Menon
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
BackgroundMatrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) play important roles in the turnover of extracellular matrix and in the pathogenesis of idiopathic pulmonary fibrosis (IPF). This study aimed to determine the utility of
Autor:
Thomas G. O'Riordan, Jenny Zhang, Emmanuel Moreau, Paul W. Noble, Kevin F. Gibson, Jin Woo Song, Fernando J. Martinez, Victoria Smith, Harold R. Collard, Athol U. Wells, Vincent Cottin, Selina Bayly, Qi Gong, Kevin K. Brown, Ganesh Raghu, Scott D. Patterson, Wim A. Wuyts, Timothy P.M. Whelan, Jason W. Chien, David J. Lederer, Robert J. Kaner
Publikováno v:
The Lancet Respiratory Medicine. 5:22-32
Summary Background Lysyl oxidase-like 2 (LOXL2) catalyses collagen cross-linking and is implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF). The aim of this study was to investigate the efficacy and safety of simtuzumab, a monoclona
Autor:
Qi Gong, John S. Sundy, Kevin K. Brown, Athol U. Wells, Paul W. Noble, Brett Ley, Scott D. Patterson, Kevin F. Gibson, Timothy P.M. Whelan, Stephen M. Humphries, Vincent Cottin, David A. Lynch, Emmanuel Moreau, Victoria C. Smith, Fernando J. Martinez, David J. Lederer, Robert J. Kaner, Krista Goodman, Jin Woo Song, Ganesh Raghu, Thomas G. O'Riordan
Publikováno v:
Thorax. 75(1)
In this retrospective study of a randomised trial of simtuzumab in idiopathic pulmonary fibrosis (IPF), prodromal decline in forced vital capacity (FVC) was significantly associated with increased risk of mortality, respiratory and all-cause hospital